Where to Buy Medical Cannabis for Glaucoma: A US Buying Guide
A US guide to buying medical cannabis for glaucoma: licensed dispensaries, delivery, telehealth cards, online retailers, dosing limits, and legal checks.
Cannabis is not an approved treatment for glaucoma. No cannabis product has FDA approval for the condition. Medical cannabis card fees run $25 to $200. A certification visit runs $100 to $300. The cannabis itself costs $300 to $600 per month at $10 per gram and 1 to 2 grams per day. Health insurance covers none of these costs.
Smoked cannabis and oral THC lower intraocular pressure in some patients. A 2017 review from the National Academies of Sciences, Engineering, and Medicine reported limited evidence of short-term IOP reduction from cannabinoids. The drop in studies from the 1970s and 1980s was 25% to 30%.
The effect lasts 3 to 4 hours. IOP returns to the starting level after that. Patients would need 6 to 8 doses per day, including at night, to hold pressure down. Tolerance builds over days to weeks, so the same dose stops working.
Is Medical Cannabis Safe for Glaucoma? A Straight Answer
Side effects include fast heart rate, low blood pressure, dizziness, impaired memory, and impaired coordination. These raise the risk of falls in older patients, who are the group most likely to have glaucoma.
medical cannabis for glaucoma treatment
The American Academy of Ophthalmology does not recommend marijuana or cannabinoids for glaucoma. The American Glaucoma Society and the Canadian Ophthalmological Society take the same position. The stated reasons are the short duration of the IOP drop and the side effect profile compared with standard care.
Dispensary flower prices range from about $5 to $20 per gram by state. At $10 per gram and 1 to 2 grams per day, flower costs $300 to $600 per month. That is $3,600 to $7,200 per year.
Tinctures, capsules, and edibles cost more per milligram of THC. Concentrates cost more per gram but carry more THC per gram.
Some states list glaucoma as a qualifying condition. Florida, Pennsylvania, Ohio, and Illinois do. Others do not. Check your state program before you pay for a visit.
No national drug code exists for cannabis, so Medicare, Medicaid, and commercial plans do not reimburse it. Employers and workers compensation programs do not either.
Eye drops are covered by most plans, with copays from $0 to $15. Medicare covers laser and surgery. Cash prices vary by pharmacy and by state.
No study has tested whether cannabis prevents vision loss from glaucoma. IOP is a surrogate marker. Long-term visual field outcomes are unmeasured. There is no standard dose, and THC and CBD content varies by product and by batch.